Inhalation Therapy Nebulizer Market

SKU: DMMD2898 | Last Updated On: Jan 12 2023 | Available Formats

Inhalation Therapy Nebulizer Market Expected to reach a high CAGR of 6.30% during 2023-2030:

Inhalation Therapy Nebulizer Market is segmented By Type (Mesh Nebulizer, Pneumatic Nebulizer, Ultrasonic Nebulizer, Jet nebulizers), By Applications (Asthma, COPD, Cystic fibrosis, Other), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Other), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030.

Inhalation therapy nebulizer market size was valued at US$ 1,055.60 million in 2021 and is estimated to reach USD million by 2030, growing at a CAGR of 6.3% during the forecast period (2023-2030). An inhalation therapy nebulizer is a medical device that converts the drug into mist and delivers it directly to the lungs. The inhalation therapy nebulization technique is commonly used to treat respiratory diseases, including asthma, cystic fibrosis, and COPD. Various devices are used for nebulization. The devices that are rechargeable and electrically powered are most widely used.

Inhalation Therapy Nebulizer Market Scope



Market CAGR


Segments Covered

 By Type, By Application, By Distribution Channel, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

To know more insights into the Global, Regional Market, Download Our Sample Brochure

Growth Dynamics

The global inhalation therapy nebulizer market growth is driven growing incidence of chronic respiratory diseases, increasing demand for home healthcare devices, and a rising geriatric population base are among the key factors driving the Inhalation Therapy Nebulizer Market growth.

The increasing prevalence of chronic respiratory diseases is expected to drive growth in the forecast period

The increasing prevalence of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population base drive the Inhalation Therapy Nebulizer Market growth. Nebulizers are respiratory drug delivery devices that transform liquid medications into aerosols (liquid particles in a gas). The drug is converted into a mist that can be directly delivered to the patient's lungs. The rising incidences of chronic respiratory diseases and rapid technological advances are among the key factors driving the usage of nebulizers. The adoption is also increasing, due to the demand for new technologies with higher quality, smaller size, lighter weight, and ease of accessibility, by the patients. Thus, the increasing demand for these devices is driving the Inhalation Therapy Nebulizer Market growth.

Increased demand for home healthcare devices is expected to drive market growth

Home healthcare devices have been gaining popularity and market share in recent years. Miniaturization of products and technological advancements boost home healthcare devices' adoption. Furthermore, rowing needs to curb healthcare expenditure is expected to be some of the high-impact rendering drivers for home healthcare devices. Home healthcare is a cost-effective alternative to expensive hospital stays, expected to boost the market. Easy availability of compact nebulizers that are ideal for home use and technological innovations in nebulizers to reduce the sound created by them and improve their functionality are increasing their adoption in-home healthcare. These factors are driving the growth of the market in the forecast period.

Side effects associated with drug inhalation are likely to hinder the market growth

However, complications and side effects associated with drug inhalation, unavailability of a single effective inhaler device, and lack of awareness are restraining the market. Global Inhalation Therapy Nebulizer Market- Industry Analysis

The global inhalation therapy nebulizer market provides in-depth analysis of the market based on various industry factors such as porter’s five force analysis, supply chain analysis, regulatory analysis, pricing analysis, pipeline analysis, epidemiology, etc.

COVID-19 Impact Analysis

Many of the patients use a home nebulizer to care for their respiratory conditions. A patient with COVID-19 or suspected COVID-19 must use a nebulizer at home. Moreover, the National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, is working with regulatory authorities to get approval for a nebulizer-based inhalation therapy it has designed for use in COVID patients. The inhalation therapy for combating COVID-19 is very effective. These factors are driving the growth of the market in the forecast period.

Segment Analysis

The mesh nebulizer segment is expected to grow at the fastest CAGR during the forecast period (2022-2029) 

The mesh nebulizer segment of the global nebulizer market is expected to witness the largest market share over the forecast period. Mesh nebulizers have become the first choice for new nebulized pharmaceutical drug developments. Thus it was estimated that mesh nebulizers will be increasingly adopted in the coming future.

This is due to the portability, convenience, and speed of treatment, owing to their low residual volumes and accurate lung delivery. Thus, technological advancements in mesh nebulizers, with the development of an innovative solution, are likely to further drive the growth of the market in the future.

According to recent facts revealed by World Health Organization, asthma is the most popular chronic disease in pediatric populations. In addition, asthma is a global health burden in high-income countries and an economic burden in low- and middle-income populations. The substantial mortality associated with asthma is fueling the demand for better aerosol drug delivery devices in the healthcare sector. The rising number of obese people the world over who are at increased risk of COPD is also bolstering the demand for mesh nebulizers.

Many companies in the market are manufacturing mesh nebulizers such as Omron Healthcare, Nulife, and Philips Healthcare are at the forefront of this market. Resipirotech Med Solutions Pvt. Ltd., Becton, Dickinson, and Co., PARI Respiratory Equipment Inc., Medicare Equipments (India) Pvt. Ltd.

In  April 2017, Bayer AG has launched Breelib™, the new nebuliser for Ventavis (iloprost), in Poland. BreelibTM has been developed by Bayer in collaboration with Vectura, adapting Vectura's FOX handheld smart nebuliser device and utilising its unique flow rate and volume control technology. The launch of the Breelib device marks an important validation of Vectura's mesh based handheld device technology using the FOX smart nebuliser.

Thus, demand for portable and high-performance, battery-operated mesh nebulizer systems in the medical industry has kept the market increasingly lucrative over the past few years

Geographical Analysis

North America region holds the largest market share of the global inhalation therapy nebulizer market

The North American market for inhalation therapy nebulizer is growing, due to continuous innovations in technology. As the population in the region follows a fast-moving lifestyle, patients are looking for more portable nebulizer devices that can be transferred easily in a time of need for patients suffering from asthma and other airway diseases.

In addition, healthcare cost containment issues, the post-economic crisis in the United States, have required the government to introduce new strategies to reduce patient stays in hospitals. This provided impetus to homecare services, which in turn, created a favorable environment for the growth of the nebulizer market. Moreover, the rising consumption of alcohol, tobacco, and ultra-processed products, including sugar-sweetened beverages is a major cause behind the increasing prevalence of respiratory diseases in North America. According to the Centers for Disease Control and Prevention (CDC) data, about 14% of deaths in adults aged 30 to 70 years in North America are caused due to tobacco consumption. Thus, an increase in the number of smokers and environmental pollution is anticipated to increase the demand for nebulizers.

Competitive Landscape

The market is moderately competitive with the presence of local as well as global companies.  Some of the key players which are contributing to the growth of the market include Rossmax International Ltd., OMRON Corporation, Koninklijke Philips N.V., PARI Pharma, BD, Medline Industries, Inc., Briggs Healthcare, GF Health Products, Inc., Vectura Group plc, Beurer GmBH among others.

Key Companies to Watch

Omron Corporation

Overview: Omron's primary business is the manufacture and sale of automation components, equipment, and systems, but it is generally known for medical equipment such as digital thermometers, blood pressure monitors and nebulizers. Omron was established by Kazuma Tateishi in 1933 (as the Tateisi Electric Manufacturing Company) and incorporated in 1948.

Product Portfolio: Portable MicroAir Battery-Operated Nebulizer- The MicroAir U100 Nebulizer is a small, handheld battery-operated nebulizer. It uses unique, vibrating mesh technology with fast misting to help deliver the optimal amount of medication.

The global inhalation therapy nebulizer market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages. 

Trending Topics

Microsurgical Instruments Market

Automated Ophthalmic Perimeters Market

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

20% Discount Applied*

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!